Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases
about
HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtinA mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardationAutophagy, mitochondria and oxidative stress: cross-talk and redox signallingCHIP: A new modulator of human malignant disordersMechanisms of islet amyloidosis toxicity in type 2 diabetesWidespread protein aggregation as an inherent part of aging in C. elegansThe Crystal Structure of the Protein-Disulfide Isomerase Family Member ERp27 Provides Insights into Its Substrate Binding CapabilitiesUnraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical InsightModulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseasesEnvironmental neurotoxin-induced progressive model of parkinsonism in rats.In vitro and in vivo neurotoxicity of prion protein oligomers.Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells.Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.Coupling endoplasmic reticulum stress to the cell death program in dopaminergic cells: effect of paraquatSelective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathyAnalysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease.Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trialsAutophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.Roles of mitochondrial ubiquitin ligase MITOL/MARCH5 in mitochondrial dynamics and diseases.Expression of α-subunit of α-glucosidase II in adult mouse brain regions and selected organsA Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its DerivativesOptimal dynamics for quality control in spatially distributed mitochondrial networks.Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration.Phenol red interacts with the protofibril-like oligomers of an amyloidogenic hexapeptide NFGAIL through both hydrophobic and aromatic contacts.LINGO-1 promotes lysosomal degradation of amyloid-β protein precursor.Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.Monodisperse carboxyl-functionalized poly(ethylene glycol)-coated magnetic poly(glycidyl methacrylate) microspheres: application to the immunocapture of β-amyloid peptides.Quantification of malondialdehyde by HPLC-FL - application to various biological samples.Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.The small chaperone protein p23 and its cleaved product p19 in cellular stress.Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degusThe aggravating role of the ubiquitin-proteasome system in neurodegeneration.Phenylbutyric acid suppresses protein accumulation-mediated ER stress in retrovirus-infected astrocytes and delays onset of paralysis in infected miceBinding of Congo red to amyloid protofibrils of the Alzheimer Aβ(9-40) peptide probed by molecular dynamics simulations.Class II G protein-coupled receptors and their ligands in neuronal function and protectionImmunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Nitro-PDI incites toxic waste accumulation.The involvement of DNA-damage and -repair defects in neurological dysfunctionDiversity of mitochondrial pathology in a mouse model of axonal degeneration in synucleinopathies.ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.
P2860
Q24337155-E3756115-B274-4429-A023-90B731C9D53CQ24532087-DFDBA705-E74C-4186-82C9-0BC353CC39DBQ24608960-5BE9E1FE-0744-473A-9175-FAC65C6F87C0Q26752358-57AAF623-F2CE-486C-B5BD-3209EBDCB57DQ26823708-C28F603A-5113-4ECF-A7EA-DBA841F3314FQ27323997-09CE4281-3A2D-4FB0-BC0F-CA610D99F2DBQ27675320-0317EE03-6D57-4CAA-8397-F37C0946942EQ28547536-A729B6B9-530A-4D15-8D9F-EAA335B88EA6Q29247921-05E055D5-589C-4EE9-A2A3-581EE90AE88EQ30497416-7460F764-2587-49AF-BB8F-AA795C1150DBQ33296885-F06B9834-3164-4309-B4CC-D0CB5F34ADAEQ33323232-06D239D4-2B43-4050-A201-B094FC53DB11Q33366459-69CC6C71-2F09-4794-9BDC-884D55C85C66Q33636122-FADD2F81-6084-4908-8C16-E64E806A5E3FQ33670282-D0CED026-6E2F-483E-BC0C-B31D9442142EQ34007682-723DB3C9-8217-47E7-B477-7FC1E356D13EQ34014237-F1BA9AC8-33BD-4042-9BFD-36FDB011C398Q34287719-0071B3AF-E6B8-4B24-8DD3-83507731AB3EQ34409467-47326137-F68D-416D-8E3B-B6BCE9224663Q34543638-384C5C52-710F-49B3-A3A0-CC94E0DAC085Q34548561-987BDD8A-33E0-495D-9464-EE33AB68EF24Q34844944-2CB8D654-5002-4824-B286-AB62719E7064Q34890838-63E53DDA-828C-43A3-AB4D-D275E880E8AFQ35121317-11365001-9DED-476F-8766-A11068F4F4CEQ35165089-DBE00344-FA44-4864-AB62-0ACC65743644Q35168349-5E58ADDC-7D20-4A1A-B68A-E2764A9F66A9Q35228880-4B19FC6E-DB9D-46D0-82BB-3007EBEAD803Q35376444-A8D5D126-4F65-41D9-AE3A-179509C6403CQ35574384-CB27ED3F-192E-4B77-8F51-F86A30DEE8C8Q35633977-99F85B64-453C-4682-9B2C-377185FC940AQ35743990-C5C82D2C-7C35-4C1C-B8BB-016CF01782E2Q36020204-23869F67-3532-4935-BB51-24691877B902Q36108977-1BC70AAA-A285-4E2B-A44E-32B3164B663DQ36150722-DA924839-7FF5-4147-B2A7-20BABD935146Q36211439-680BF283-F636-4718-9C5A-84A1A6976E72Q36484413-52C6611F-79E9-4E24-8145-1F19DB07D1AAQ36519861-C0D653CD-791E-417E-9D9A-0BB88CD46C0FQ36718848-686DE9B1-90E5-4B20-8614-61B4C5E10557Q36729178-E000B3A3-EF5F-448C-A720-DAF71E2D4004Q36842266-E0A0B761-F752-4C53-B8DA-B2A9501C9B1D
P2860
Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@ast
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en-gb
Role of protein aggregation in ...... mer's and Parkinson's diseases
@nl
type
label
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@ast
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en-gb
Role of protein aggregation in ...... mer's and Parkinson's diseases
@nl
altLabel
Role of protein aggregation in ...... mer's and Parkinson's diseases
@en
prefLabel
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@ast
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en-gb
Role of protein aggregation in ...... mer's and Parkinson's diseases
@nl
P921
P3181
P356
P1476
Role of Protein Aggregation in ...... mer's and Parkinson's Diseases
@en
Role of protein aggregation in ...... mer's and Parkinson's diseases
@en
P2093
Leslie Crews
Makoto Hashimoto
P2888
P3181
P356
10.1385/NMM:4:1-2:21
P407
P577
2003-01-01T00:00:00Z
P6179
1008334791